Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

iHuman (IH) EBITDA (2019 - 2025)

Historic EBITDA for iHuman (IH) over the last 7 years, with Q3 2025 value amounting to $16.7 million.

  • iHuman's EBITDA fell 1947.53% to $16.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.7 million, marking a year-over-year decrease of 8144.21%. This contributed to the annual value of $14.3 million for FY2024, which is 4596.48% down from last year.
  • Per iHuman's latest filing, its EBITDA stood at $16.7 million for Q3 2025, which was down 1947.53% from $19.5 million recorded in Q2 2025.
  • Over the past 5 years, iHuman's EBITDA peaked at $334.6 million during Q4 2023, and registered a low of -$43.9 million during Q3 2021.
  • In the last 5 years, iHuman's EBITDA had a median value of $19.5 million in 2025 and averaged $34.7 million.
  • Its EBITDA has fluctuated over the past 5 years, first tumbled by 42395.69% in 2021, then soared by 75498.26% in 2022.
  • Quarter analysis of 5 years shows iHuman's EBITDA stood at -$10.6 million in 2021, then surged by 470.09% to $39.1 million in 2022, then surged by 754.94% to $334.6 million in 2023, then tumbled by 95.54% to $14.9 million in 2024, then grew by 11.72% to $16.7 million in 2025.
  • Its EBITDA was $16.7 million in Q3 2025, compared to $19.5 million in Q2 2025 and $21.6 million in Q1 2025.